Publications by authors named "A Kouassi"

Claim this Profile
S
Safety and immunogenicity of a single dose of a JN.1 variant COVID-19 vaccine in previously vaccinated adults: Primary analysis report of a phase 3 open-label trial.
Katia Alves, Alex Kouassi, Joy Nelson, Joyce S Plested, Raj Kalkeri

Vaccine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unsung climate guardians: The overlooked role of remnant and spontaneous trees in carbon stocks and gains from tree growth in West African cocoa fields.
Isaac Kouamé Konan, Anny Estelle N'Guessan, Aimé Kouassi, Marie Ruth Dago, Justin Kassi N'Dja

PLoS One· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study.
Katia Alves, Karen Kotloff, R Scott McClelland, Alex Kouassi, Joyce S Plested

Lancet Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label study.
Katia Alves, Alex Kouassi, Joyce S Plested, Raj Kalkeri, Katherine Smith

Vaccine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Level of involvement of four selected cytochrome P450s (CYPs) in pyrethroid-resistant () and across Côte d'Ivoire.
Joseph Chabi, Constant V A Edi, Bernard L Kouassi, Constant N G Gbalegba, Armand E Kouassi

Curr Res Parasitol Vector Borne Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis